loader image
Sunday, December 21, 2025
66.3 F
McAllen
- Advertisement -

Many Patients Receive Too Little Rehab Following a Stroke

Hispanic patients also received disproportionately lower amounts of rehab

Translate to Spanish or other 102 languages!

Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy. Image for illustration purposes
Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy. Image for illustration purposes

Mega Doctor News

- Advertisement -

By University of California, Los Angeles (UCLA), Health Sciences

Newswise — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence that higher amounts can reduce long-term disability, according to a new UCLA-led study that tracked over 500 patients across 28 acute care hospitals in their first year following a stroke.

The new research, published in the peer-reviewed journal Stroke, is the first U.S.-wide study to find that patients who had more severe strokes received higher amounts of rehabilitation therapy, a welcome finding. “But in the bigger picture, the findings reinforce that too many patients are missing out on a golden opportunity to maximize recovery during a critical period following a stroke,” said the study’s lead author, Steven Cramer, MD. Stroke is a leading cause of long-term disability in the United States and can affect speech, memory, and mobility, among other impairments.

- Advertisement -

“In the initial weeks after a stroke, the brain is ready to undergo maximum rewiring to get people back on their feet. Rehab therapy helps maximize this recovery, with higher rehab therapy doses helping more, but what we found in this study is that most patients are getting rather small doses of rehab therapy,” said Dr. Cramer, a stroke neurologist and professor of neurology at the David Geffen School of Medicine at UCLA and the California Rehabilitation Institute.

Among the study’s key findings:

–Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy.

–Those who did receive rehabilitation therapy typically had six to eight sessions by three months after their stroke – and between 0 and 1.5 sessions the rest of the year.

- Advertisement -

–Where patients were sent following hospitalization also mattered. Those who were discharged home had the lowest levels of rehabilitation therapy, regardless of the severity of their stroke.

–Hispanic patients received disproportionately lower amounts of physical therapy and occupational therapy.

Cramer said it is important for future research to examine the feasibility of providing higher therapy doses to stroke patients.

The other study authors are Brittany Young, MD, PhD, of UCLA and the California Rehabilitation Institute, and Alison Holman, PhD, FNP, of the Sue and Bill Gross School of Nursing at UC-Irvine.

Journal Link: Stroke

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×